Specialized diagnostics Target health systems and clinics focusing on infectious disease diagnostics, emphasizing access to proprietary H. pylori antibiotic resistance panel to address treatment-resistant cases and differentiate from standard panels.

Mid-market growth Position AML as a high-skill, mid-range supplier with annual revenue in the ten millions, aiming at mid-tier reference labs and regional hospital networks that seek specialized molecular capabilities without engaging with mega-lab incumbents.

Technology leverage Leverage the existing tech stack and modern digital presence to offer scalable LIMS-integrated testing, online scheduling, and remote result delivery to streamline adoption for partner laboratories.

Competitive landscape Differentiate from larger national players by marketing agility, specialized panels, and rapid turnaround in gastrointestinal and respiratory infectious diseases to win RFPs from regional health systems seeking niche expertise.

Growth opportunities Explore partnerships for contract research, clinical trials support, and expansion into additional infectious disease panels to broaden service scope, increase order value, and attract larger multi-site networks.